Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines

mRNA vaccines against cancer have advantages in safety, improved therapeutic efficacy, and large-scale production. Therefore, our purpose is to identify immune biomarkers and to analyze immune status for developing mRNA vaccines and selecting appropriate patients for vaccination. We downloaded clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Tan, Huaicheng, Yu, Ting, Chen, Xiaoxuan, Jing, Fangqi, Shi, Huashan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670181/
https://www.ncbi.nlm.nih.gov/pubmed/34917077
http://dx.doi.org/10.3389/fimmu.2021.755401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670181/
https://www.ncbi.nlm.nih.gov/pubmed/34917077
http://dx.doi.org/10.3389/fimmu.2021.755401

Ejemplares similares